LIA
NYMX

LS Investment Advisors’s Nymox Pharmaceutical Corp NYMX Stock Holding History

LS Investment Advisors’s Portfolio NYMX Stock Details NYMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-3,000
Closed -$11K – 1548
2020
Q2 		$11K Hold
3,000
– – ﹤0.01% 1519
2020
Q1 		$7K Hold
3,000
– – ﹤0.01% 1612
2019
Q4 		$7K Hold
3,000
– – ﹤0.01% 1694
2019
Q3 		$6K Hold
3,000
– – ﹤0.01% 1688
2019
Q2 		$4K Hold
3,000
– – ﹤0.01% 1701
2019
Q1 		$6K Hold
3,000
– – ﹤0.01% 1668
2018
Q4 		$4K Hold
3,000
– – ﹤0.01% 1678
2018
Q3 		$7K Hold
3,000
– – ﹤0.01% 1752
2018
Q2 		$10K Hold
3,000
– – ﹤0.01% 1709
2018
Q1 		$13K Buy
+3,000
New +$10.4K ﹤0.01% 1660

Other funds holding NYMX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

LS Investment Advisors's NYMX Position: Q3 2020 in Review

LS Investment Advisors sold out of Nymox Pharmaceutical Corp (NYMX) in Q3 2020, closing a stake of 3,000 shares — an estimated $11K sold.

LS Investment Advisors first reported a position in NYMX in Q1 2018 and held it in 10 quarters. The position peaked at $13K in Q1 2018. 64 funds tracked by Wall St. Rank hold NYMX as of Q3 2020.

  • LS Investment Advisors reported no remaining Nymox Pharmaceutical Corp position as of Q3 2020 after selling out during the quarter.
  • LS Investment Advisors sold 3,000 Nymox Pharmaceutical Corp shares in Q3 2020, an estimated $11K.
  • LS Investment Advisors first reported a position in Nymox Pharmaceutical Corp in Q1 2018 and held it in 10 quarters.
  • LS Investment Advisors's Nymox Pharmaceutical Corp position peaked at $13K in Q1 2018.
  • 64 funds tracked by Wall St. Rank held Nymox Pharmaceutical Corp as of Q3 2020.

Based on LS Investment Advisors's 13F filing for Q3 2020, filed 12 Nov 2020.